Modeling approaches to inform every development decision.
Find in one place the key solutions offered by PhinC to support your development programs: from mechanistic understanding to clinical trial simulation, including PK/PD analysis, cardiac safety, non-compartmental pharmacokinetics, and advanced systems approaches.
PBPK
Anticipate the behavior of your drug candidate through a mechanistic approach that integrates physiology, compound properties, and experimental data to support and de-risk preclinical and clinical decisions.
- ADME prediction
- First-in-human
- DDI & food effect
- Special populations
QSP
Explore the biological complexity of your mechanisms of action with systems models capable of linking biology, pharmacology, and therapeutic hypotheses to guide your development strategy.
- Mechanistic modeling
- Systems perspective
- Hypothesis exploration
- Translational support
PK NCA - CDISC
Strengthen the reliability of your non-compartmental pharmacokinetic analyses and structure your data according to expected standards to improve the quality, traceability, and compliance of your deliverables.
- NCA analysis
- CDISC standards
- Quality & compliance
- Submission-ready deliverables
Pop PK / PD
Quantify variability, characterize exposure–response relationships, and identify dose optimization levers to build a development strategy that is more robust, clearer, and better substantiated.
- Exposure–response analysis
- Inter-individual variability
- Dose optimization
- Clinical decision support
QT / QTc
Evaluate the proarrhythmic risk of your compounds using a quantitative approach dedicated to cardiac safety, supporting development decisions and regulatory interactions with robust and actionable analyses.
- Cardiac safety
- Concentration–QTc analysis
- Regulatory Support
- Integrated interpretation
Clinical Trial Simulation (CTS)
Simulate different clinical trial scenarios to test your hypotheses, compare study designs, reduce uncertainty, and select the most relevant options before committing critical resources.
- Trial design comparison
- In silico scenarios
- Decision support
- Data Analysis and Interpretation
Need to identify the most relevant approach for your program?
Our experts help you select the most appropriate modeling strategy based on your development stage, objectives, and regulatory considerations.
Book a call with an expert